Todavía no hay suficientes señales de compra con un horizonte T+90 consolidado para medir un historial.
Historial de señales
Browse the complete record of transactions filed by Hively Brad, Director General. Director active across 2 companies, notably Oncology Institute, Inc.. Aggregated, 23 reports have been published. Split: 2 buys · 4 sells. Total volume traded: €1.8m. History available since 12 January 2021. The latest transaction was filed on 21 August 2026 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Hively Brad
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Hively Brad is Directeur Général and a director of Oncology Institute, Inc. (XNAS). He has 21 filings in total, and across the sampled recent filings between 2021-11-16 and 2025-12-16, the buy and sell amounts are 52470 EUR and 221478 EUR, respectively, with the modal transaction nature listed as Attribution.